溃疡性结肠炎急性发作住院患者的临床试验设计考量及在NIDDK HBOT-UC联盟高压氧治疗研究中的应用
该文由多中心联盟制定溃疡性结肠炎住院患者临床试验设计框架,涉及入排标准、疾病活动度评估、实用试验设计、护理路径标准化、主要和次要结局及样本量与统计方法,并应用于高压氧治疗试验。
要点
- Truelove-Witt标准不应单独用于定义入组人群。
- 内镜对确定合格人群至关重要,患者报告结局应包括直肠出血和排便频率。
- 试验设计需贴合护理路径,PRECIS-2框架可用于适应当地人群。
核心结论
- 本文提供了针对溃疡性结肠炎发作住院患者高压氧试验的框架决策概要,未来研究应聚焦于已识别的剩余缺口。
研究设计与样本
- 多中心联盟设计并开展针对因中度至重度发作住院的溃疡性结肠炎患者的新型治疗干预(高压氧治疗)临床试验。
主要发现
- Truelove-Witt标准不应单独使用,内镜对定义合格人群至关重要。
- 患者报告结局应包括直肠出血和排便频率,并次要测量急迫感和夜间排便。
- 试验设计需贴合护理路径,早期干预侧重于替代和/或优化对类固醇的反应性,后期干预侧重于测试新型挽救药物或策略。
- PRECIS-2框架提供了适应当地人群的手段。
- 提供了基线检查、静脉血栓预防、类固醇给药、出院标准和出院后随访的标准化,以避免常规护理变异带来的混杂。
关键数值与推荐
- Truelove-Witt标准不应单独用于定义入组人群。
- 患者报告结局应包括直肠出血和排便频率,次要测量急迫感和夜间排便。
- 早期干预侧重于替代和/或优化对类固醇的反应性,后期干预侧重于测试新型挽救药物或策略。
- 提供了基线检查、静脉血栓预防、类固醇给药、出院标准和出院后随访的标准化。
临床怎么用
- 原文未据此给出推荐。
局限性
- 未来研究应聚焦于已识别的剩余缺口。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Patients with ulcerative colitis (UC) who are hospitalised for acute severe flares represent a high-risk orphan population. AIM: To provide guidance for clinical trial design methodology in these patients. METHODS: We created a multi-centre consortium to design and conduct a clinical trial for a novel therapeutic intervention (hyperbaric oxygen therapy) in patients with UC hospitalised for moderate-severe flares. During planning, we identified and addressed specific gaps for inclusion/exclusion criteria; disease activity measures; pragmatic trial design considerations within care pathways for hospitalised patients; standardisation of care delivery; primary and secondary outcomes; and sample size and statistical analysis approaches. RESULTS: The Truelove-Witt criteria should not be used in isolation. Endoscopy is critical for defining eligible populations. Patient-reported outcomes should include rectal bleeding and stool frequency, with secondary measurement of urgency and nocturnal bowel movements. Trial design needs to be tailored to care pathways, with early intervention focused on replacing and/or optimising responsiveness to steroids and later interventions focused on testing novel rescue agents or strategies. The PRECIS-2 framework offers a means of tailoring to local populations. We provide standardisation of baseline testing, venous thromboprophylaxis, steroid dosing, discharge criteria and post-discharge follow-up to avoid confounding by usual care variability. Statistical considerations are provided given the small clinical trial nature of this population. CONCLUSION: We provide an outline for framework decisions made for the hyperbaric oxygen trial in patients hospitalised for UC flares. Future research should focus on the remaining gaps identified.
引用
- Dulai PS, Bonner LB, Sadler C, et al. Clinical Trial Design Considerations for Hospitalised Patients With Ulcerative Colitis Flares and Application to Study Hyperbaric Oxygen Therapy in the NIDDK HBOT-UC Consortium. Aliment Pharmacol Ther. 2024. PMID: 39403018. doi:10.1111/apt.18326
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。